Grail

Biotech has become one of the hottest areas of venture investment in recent years, as progress in machine learning, genetics, medical devices and biology fuse together into new products for the gargan

Bit Bio, the new startup that pitches itself as the “enter button for the keyboard to the software of life,” only needed three weeks to raise its latest $41.5 million round of funding. Ori

Visual assessment is critical to healthcare -- whether that is a doctor peering down your throat as you say “ahhh” or an MRI of your brain.

Just months after Grail raised a $900 million Series B round, the startup that aims to detect cancer early on is looking for additional funding, CNBC reports. Prior to the $900 million round, Grail ra

Life sciences startups need a whole lot more cash than most and that’s certainly true for GRAIL, a cancer detection startup trying to figure out a way to find the “emperor of all maladies&

The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only menti

Yesterday afternoon, before he took the stage at the Fortune’s Brainstorm Tech conference, we sat down with GV CEO Bill Maris in a billowing white tent on the campus of the Aspen Institute, whe